NasdaqGS:MDRX

Stock Analysis Report

Allscripts Healthcare Solutions

Executive Summary

Allscripts Healthcare Solutions, Inc. provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally.

Snowflake

Fundamentals

Moderate growth potential and slightly overvalued.


Similar Companies

Share Price & News

How has Allscripts Healthcare Solutions's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

5.2%

MDRX

-1.5%

US Healthcare Services

1.0%

US Market


1 Year Return

-18.6%

MDRX

16.4%

US Healthcare Services

8.0%

US Market

Return vs Industry: MDRX underperformed the US Healthcare Services industry which returned 16.4% over the past year.

Return vs Market: MDRX underperformed the US Market which returned 8% over the past year.


Shareholder returns

MDRXIndustryMarket
7 Day5.2%-1.5%1.0%
30 Day0.2%-3.7%-0.07%
90 Day2.8%-6.6%-1.0%
1 Year-18.6%-18.6%16.6%16.4%10.4%8.0%
3 Year-13.1%-13.1%64.0%63.4%46.2%36.7%
5 Year-19.8%-19.8%63.2%61.7%64.3%46.2%

Price Volatility Vs. Market

How volatile is Allscripts Healthcare Solutions's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Allscripts Healthcare Solutions undervalued compared to its fair value and its price relative to the market?

21.3%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: MDRX ($10.92) is trading below our estimate of fair value ($13.87)

Significantly Below Fair Value: MDRX is trading below fair value, but not by a significant amount.


Price To Earnings Ratio

PE vs Industry: MDRX is unprofitable, so we can't compare its PE Ratio to the Healthcare Services industry average.

PE vs Market: MDRX is unprofitable, so we can't compare its PE Ratio to the US market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate MDRX's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: MDRX is good value based on its PB Ratio (1.4x) compared to the US Healthcare Services industry average (3.4x).


Next Steps

Future Growth

How is Allscripts Healthcare Solutions forecast to perform in the next 1 to 3 years based on estimates from 17 analysts?

71.0%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: MDRX is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.7%).

Earnings vs Market: MDRX is forecast to become profitable over the next 3 year, which is considered above average market growth.

High Growth Earnings: MDRX's loss is forecast to worsen by 0% next year.

Revenue vs Market: MDRX's revenue (4.9% per year) is forecast to grow slower than the US market (7.2% per year).

High Growth Revenue: MDRX's revenue (4.9% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: MDRX's Return on Equity is forecast to be low in 3 years time (9.7%).


Next Steps

Past Performance

How has Allscripts Healthcare Solutions performed over the past 5 years?

-3.9%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Earnings Trend: MDRX is unprofitable, and losses have increased over the past 5 years at a rate of -3.9% per year.

Accelerating Growth: Unable to compare MDRX's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: MDRX is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (-1.2%).


Return on Equity

High ROE: MDRX has a negative Return on Equity (-15.55%), as it is currently unprofitable.


Return on Assets

ROA vs Industry: MDRX is currently unprofitable, so its Return on Assets is negative.


Return on Capital Employed

ROCE Improving: MDRX is currently unprofitable, so its Return on Capital Employed is negative.


Next Steps

Financial Health

How is Allscripts Healthcare Solutions's financial position?


Financial Position Analysis

Short Term Liabilities: MDRX's short term assets ($804.1M) do not cover its short term liabilities ($879.8M)

Long Term Liabilities: MDRX's short term assets (804.1M) do not cover its long term liabilities (1.0B)


Debt to Equity History and Analysis

Debt Level: MDRX's debt to equity ratio (64.2%) is considered high

Reducing Debt: MDRX's debt to equity ratio has increased from 43% to 64.2% over the past 5 years.


Balance Sheet

Inventory Level: MDRX has a low level of unsold assets or inventory.

Debt Coverage by Assets: MDRX's debt is not covered by short term assets (assets are 1x debt).


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: MDRX has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: Insufficient data to determine if MDRX has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.


Next Steps

Dividend

What is Allscripts Healthcare Solutions's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

companyn/amarketbottom25%1.4%markettop25%3.7%industryaverage1.0%forecastin3Years0%

Current dividend yield vs market & industry


Stability and Growth of Payments

Notable Dividend: Unable to evaluate MDRX's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.

High Dividend: Unable to evaluate MDRX's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.

Stable Dividend: Insufficient data to determine if MDRX's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if MDRX's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of MDRX's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

What is the CEO of Allscripts Healthcare Solutions's salary, the management and board of directors tenure and is there insider trading?

2.4yrs

Average management tenure


CEO

Paul Black (61yo)

6.8yrs

Tenure

US$7,801,251

Compensation

Mr. Paul M. Black has been the Chief Executive Officer of Allscripts Healthcare Solutions, Inc. since December 19, 2012. Mr. Black serves as an Adjunct Professor of Businss at the University of Missouri –  ...


CEO Compensation Analysis

Compensation vs. Market: Paul's total compensation ($USD7.80M) is above average for companies of similar size in the US market ($USD4.07M).

Compensation vs Earnings: Paul's compensation has increased whilst the company is unprofitable.


Management Age and Tenure

2.4yrs

Average Tenure

54yo

Average Age

Experienced Management: MDRX's management team is considered experienced (2.4 years average tenure).


Board Age and Tenure

3.8yrs

Average Tenure

62.5yo

Average Age

Experienced Board: MDRX's board of directors are considered experienced (3.8 years average tenure).


Insider Trading

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

BuyUS$99,84117 Dec 18
Jonathan Judge
EntityIndividual
Role
Member of the Board of Directors
Director
Shares9,622
Max PriceUS$10.38
BuyUS$10,00617 Dec 18
Mara Aspinall
EntityIndividual
Role
Member of the Board of Directors
Director
Shares963
Max PriceUS$10.39
BuyUS$9,79817 Dec 18
P. Garrison
EntityIndividual
Role
Member of the Board of Directors
Director
Shares1,000
Max PriceUS$9.80
SellUS$589,23314 Dec 18
Richard Poulton
EntityIndividual
Role
President
President
Shares60,000
Max PriceUS$9.86
BuyUS$250,02713 Dec 18
Paul Black
EntityIndividual
Role
Chief Executive Officer
CEO & Director
Shares24,765
Max PriceUS$10.10
BuyUS$120,84013 Dec 18
Yancey Spruill
EntityIndividual
Role
Member of the Board of Directors
Director
Shares12,000
Max PriceUS$10.07

Ownership Breakdown


Management Team

  • Paul Black (61yo)

    CEO & Director

    • Tenure: 6.8yrs
    • Compensation: US$7.80m
  • Rick Poulton (54yo)

    President

    • Tenure: 4yrs
    • Compensation: US$5.50m
  • Stephen Shulstein

    Vice President of Investor Relations

    • Tenure: 1.3yrs
  • Paul Lewis

    Senior Vice President of Sales & Services and Acting General Manager

    • Tenure: 12.8yrs
  • Rich Elmore

    Senior Vice President of Corporate Development & Strategy

    • Tenure: 0.8yrs
  • Steve Lalonde

    Senior VP & GM of Ambulatory

    • Tenure: 0yrs
  • Dennis Olis (56yo)

    Chief Financial Officer

    • Tenure: 2.4yrs
    • Compensation: US$2.50m
  • Brian Farley (49yo)

    Executive VP

    • Tenure: 2.2yrs
    • Compensation: US$2.92m
  • Lisa Khorey (52yo)

    Executive VP & Chief Client Delivery Officer

    • Tenure: 2.9yrs
    • Compensation: US$2.98m
  • Leah Jones

    Senior Vice President of Sales Operations

    • Tenure: 0.8yrs

Board Members

  • David Stevens (65yo)

    Director

    • Tenure: 7.8yrs
    • Compensation: US$303.00k
  • Paul Black (61yo)

    CEO & Director

    • Tenure: 6.8yrs
    • Compensation: US$7.80m
  • Jon Judge (65yo)

    Director

    • Tenure: 3.4yrs
    • Compensation: US$294.40k
  • Michael Klayko (64yo)

    Chairman of the Board

    • Tenure: 5.6yrs
    • Compensation: US$427.75k
  • Yancey Spruill (51yo)

    Director

    • Tenure: 3.4yrs
    • Compensation: US$273.00k
  • Dave Stevens (56yo)

    Director

    • Tenure: 3.4yrs
    • Compensation: US$271.50k
  • Mara Aspinall (57yo)

    Director

    • Tenure: 2.4yrs
    • Compensation: US$274.50k
  • Greg Garrison (65yo)

    Director

    • Tenure: 4.3yrs
    • Compensation: US$304.50k

Company Information

Allscripts Healthcare Solutions, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Allscripts Healthcare Solutions, Inc.
  • Ticker: MDRX
  • Exchange: NasdaqGS
  • Founded: 1986
  • Industry: Health Care Technology
  • Sector: Healthcare
  • Market Cap: US$1.820b
  • Shares outstanding: 166.65m
  • Website: https://www.allscripts.com

Number of Employees


Location

  • Allscripts Healthcare Solutions, Inc.
  • 222 Merchandise Mart Plaza
  • Suite 2024
  • Chicago
  • Illinois
  • 60654
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
MDRXNasdaqGS (Nasdaq Global Select)YesCommon SharesUSUSDMar 2006
AL21DB (Deutsche Boerse AG)YesCommon SharesDEEURMar 2006

Biography

Allscripts Healthcare Solutions, Inc. provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health recor ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/10/21 23:31
End of Day Share Price2019/10/21 00:00
Earnings2019/06/30
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.